Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1982 Apr;36(1):426–429. doi: 10.1128/iai.36.1.426-429.1982

Involvement of prostaglandin E1 in delayed-type hypersensitivity suppression induced with live Mycobacterium bovis BCG.

K Kato, K Yamamoto
PMCID: PMC351236  PMID: 7042574

Abstract

We previously showed the suppression of delayed-type hypersensitivity produced by live BCG-induced, plastic-adhering cells. The present study was undertaken to determine whether prostaglandin was one of the pharmacological mediators involved in this suppression. A high level of prostaglandin E1 was detected in the culture supernatant fluid of the live BCG-induced, adherent cells. Moreover, prostaglandin E1 could suppress the macrophage migration inhibition activity of peritoneal exudate cells from BCG cell wall-sensitized mice.

Full text

PDF
428

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bourne H. R., Lichtenstein L. M., Melmon K. L., Henney C. S., Weinstein Y., Shearer G. M. Modulation of inflammation and immunity by cyclic AMP. Science. 1974 Apr 5;184(4132):19–28. doi: 10.1126/science.184.4132.19. [DOI] [PubMed] [Google Scholar]
  2. Brune K., Glatt M., Kälin H., Peskar B. A. Pharmacological control of prostaglandin and thromboxane release from macrophages. Nature. 1978 Jul 20;274(5668):261–263. doi: 10.1038/274261a0. [DOI] [PubMed] [Google Scholar]
  3. Gemsa D., Seitz M., Kramer W., Till G., Resch K. The effects of phagocytosis, dextran sulfate, and cell damage on PGE1 sensitivity and PGE1 production of macrophages. J Immunol. 1978 Apr;120(4):1187–1194. [PubMed] [Google Scholar]
  4. Goodwin J. S., Bankhurst A. D., Messner R. P. Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell. J Exp Med. 1977 Dec 1;146(6):1719–1734. doi: 10.1084/jem.146.6.1719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gordon D., Bray M. A., Morley J. Control of lymphokine secretion by prostaglandins. Nature. 1976 Jul 29;262(5567):401–402. doi: 10.1038/262401a0. [DOI] [PubMed] [Google Scholar]
  6. Grimm W., Seitz M., Kirchner H., Gemsa D. Prostaglandin synthesis in spleen cell cultures of mice injected with Corynebacterium parvum. Cell Immunol. 1978 Oct;40(2):419–426. doi: 10.1016/0008-8749(78)90349-0. [DOI] [PubMed] [Google Scholar]
  7. Henney C. S., Bourne H. R., Lichtenstein L. M. The role of cyclic 3',5' adenosine monophosphate in the specific cytolytic activity of lymphocytes. J Immunol. 1972 Jun;108(6):1526–1534. [PubMed] [Google Scholar]
  8. Humes J. L., Bonney R. J., Pelus L., Dahlgren M. E., Sadowski S. J., Kuehl F. A., Jr, Davies P. Macrophages synthesis and release prostaglandins in response to inflammatory stimuli. Nature. 1977 Sep 8;269(5624):149–151. doi: 10.1038/269149a0. [DOI] [PubMed] [Google Scholar]
  9. Inagawa T., Ohki S., Sawada M., Hirata F. [Studies on extraction, separation and estimation of prostaglandins by radioimmunoassay]. Yakugaku Zasshi. 1972 Oct;92(10):1187–1194. doi: 10.1248/yakushi1947.92.10_1187. [DOI] [PubMed] [Google Scholar]
  10. Jaffe B. M., Behrman H. R., Parker C. W. Radioimmunoassay measurement of prostaglandins E, A, and F in human plasma. J Clin Invest. 1973 Feb;52(2):398–405. doi: 10.1172/JCI107196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jaffe B. M., Smith J. W., Newton W. T., Parker C. W. Radioimmunoassay for prostaglandins. Science. 1971 Feb 5;171(3970):494–496. doi: 10.1126/science.171.3970.494. [DOI] [PubMed] [Google Scholar]
  12. Kato K., Yamamoto K. I., Kakinuma M., Ishihara C., Azuma I. Suppression of BCG cell wall induced delayed-type hypersensitivity by BCG pre-treatment. I. Induction of adherent suppressor cells by live BCG injection and their characterization. Immunology. 1981 Feb;42(2):259–266. [PMC free article] [PubMed] [Google Scholar]
  13. Kirchner H., Holden H. T., Herberman Splenic suppressor macrophages induced in mice by injection of Corynebacterium parvum. J Immunol. 1975 Nov;115(5):1212–1216. [PubMed] [Google Scholar]
  14. Kurland J. I., Bockman R. Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages. J Exp Med. 1978 Mar 1;147(3):952–957. doi: 10.1084/jem.147.3.952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lomnitzer R., Rabson A. R., Koornhof H. J. The effects of cyclic AMP on leucocyte inhibitory factor (LIF) production and on the inhibition of leucocyte migration. Clin Exp Immunol. 1976 Apr;24(1):42–48. [PMC free article] [PubMed] [Google Scholar]
  16. Melmon K. L., Bourne H. R., Weinstein Y., Shearer G. M., Kram J., Bauminger S. Hemolytic plaque formation by leukocytes in vitro. Control by vasoactive hormones. J Clin Invest. 1974 Jan;53(1):13–21. doi: 10.1172/JCI107530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Metzger Z., Hoffeld J. T., Oppenheim J. J. Macrophage-mediated suppression. I. Evidence for participation of both hdyrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation. J Immunol. 1980 Feb;124(2):983–988. [PubMed] [Google Scholar]
  18. Parnham M. J., Schoester G. A., van der Kwast T. H. Enhancement by prostaglandin E1 and essential fatty acid deficiency of the passive transfer of delayed hypersensitivity to PPD in rats. Comparison with effects on delayed hypersensitivity to SRBC in mice. Int J Immunopharmacol. 1979;1(2):119–126. doi: 10.1016/0192-0561(79)90014-6. [DOI] [PubMed] [Google Scholar]
  19. Passwell J. H., Dayer J. M., Merler E. Increased prostaglandin production by human monocytes after membrane receptor activation. J Immunol. 1979 Jul;123(1):115–120. [PubMed] [Google Scholar]
  20. Pelus L. M., Strausser H. R. Indomethacin enhancement of spleen-cell responsiveness to mitogen stimulation in tumorous mice. Int J Cancer. 1976 Nov 15;18(5):653–660. doi: 10.1002/ijc.2910180514. [DOI] [PubMed] [Google Scholar]
  21. Quagliata F., Lawrence V. J., Phillips-Quagliata J. M. Prostaglandin E 1 as a regulator of lymphocyte function. Selective action on B lymphocytes and synergy with procarbazine in depression of immune responses. Cell Immunol. 1973 Mar;6(3):457–465. doi: 10.1016/0008-8749(73)90044-0. [DOI] [PubMed] [Google Scholar]
  22. Scott M. T. Biological effects of the adjuvant Corynebacterium parvum. II. Evidence for macrophage-T-cell interaction. Cell Immunol. 1972 Nov;5(3):469–479. doi: 10.1016/0008-8749(72)90073-1. [DOI] [PubMed] [Google Scholar]
  23. Smith J. W., Steiner A. L., Parker C. W. Human lymphocytic metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin. J Clin Invest. 1971 Feb;50(2):442–448. doi: 10.1172/JCI106511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232–235. doi: 10.1038/newbio231232a0. [DOI] [PubMed] [Google Scholar]
  25. Webb D. R., Jr, Jamieson T. Control of mitogen-induced transformation: characterization of a splenic suppressor cell and its mode of action. Cell Immunol. 1976 Jun 1;24(1):45–57. doi: 10.1016/0008-8749(76)90130-1. [DOI] [PubMed] [Google Scholar]
  26. Webb D. R., Nowowiejski I. The role of prostaglandins in the control of the primary 19S immune response to sRBC. Cell Immunol. 1977 Sep;33(1):1–10. doi: 10.1016/0008-8749(77)90129-0. [DOI] [PubMed] [Google Scholar]
  27. Zimecki M., Webb D. R. The regulation of the immune response to T-independent antigens by prostaglandins and B cells. J Immunol. 1976 Dec;117(6):2158–2164. [PubMed] [Google Scholar]
  28. Zurier R. B., Quagliata F. Effect of prostaglandin E 1 on adjuvant arthritis. Nature. 1971 Dec 3;234(5327):304–305. doi: 10.1038/234304a0. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES